— Know what they know.
Not Investment Advice
Also trades as: 2005.HK (HKSE) · $vol 2M

LJUIF OTC

SSY Group Limited
1W: +0.0% 1M: +1.8% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -38.5% 5Y: -15.6%
$0.40
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 59 · $1.2B mcap · 988M float · 0.0001% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$491M -47.0% ▼
5Y CAGR: -6.0%
Capital Expenditures
$540M -23.7% ▼
5Y CAGR: -7.9%
Free Cash Flow
-$49M -110.1% ▼
Dividends Paid
$534M -19.9% ▼
Buybacks
$45M -35.2% ▼
Net Change in Cash
-$358M -583.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$612M$786M$1.1B$1.3B$1.3B
Depreciation & Amort.$317M$390M$371M$406M$456M
Stock-Based Comp.$0$67M$0$0$0
Change in Working Capital-$335M-$487M-$745M-$774M-$927M
Other Non-Cash Items-$67M$1.4B-$15M-$24M-$319M
Operating Cash Flow$528M$748M$734M$926M$491M
— Investing Activities —
Capital Expenditures-$291M-$388M-$418M-$437M-$346M
Acquisitions (Net)$48M$39M$51M$0$0
Investment Purchases-$45M-$451M-$59M$0-$95M
Investment Sales$98M$119M$13M$0$0
Other Investing-$98M$0$10M-$203M-$80M
Investing Cash Flow-$288M-$681M-$403M-$640M-$522M
— Financing Activities —
Net Debt Issuance$672M$633M$260M$183M$318M
Stock Repurchased-$99M-$188M-$86M-$33M-$45M
Dividends Paid-$333M-$303M-$388M-$446M-$534M
Other Financing$127M-$7M$23M-$9M-$35M
Financing Cash Flow$366M$136M-$191M-$305M-$295M
Net Change in Cash$628M$244M$6M-$52M-$358M
Cash End of Period$1.5B$1.7B$1.7B$1.6B$1.3B
Free Cash Flow$237M$360M$369M$489M-$49M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms